MagVenture’s depression treatment MagVita TMS Therapy® based on rTMS (repetitive transcranial magnetic stimulation) allows psychiatrists to treat the large number of patients not responding to medications or who cannot tolerate side effects such as weight gain and sleep disorder.
MagVita TMS Therapy® is effective and easy to use for psychiatrists who wish to give their patients an alternative to antidepressants. A full TMS depression treatment for patients who have been properly diagnosed by a psychiatrist and found suitable for rTMS depression treatment includes 5 treatment sessions per week during a period of normally 4-6 weeks.
MagVita TMS Therapy® has been CE approved for “Treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode”.
MagVita TMS Therapy® has been FDA cleared for "Treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode". US customers please visit this page.